KLING DOUGLAS F (Chief Operating Officer) sold 69.4% of their position (100K shares) of NEWAMSTERDAM PHARMA CO N.V. on the open market
Insider sale on the open market — a major position exit. Check remaining position size for full context.
S · 1 sale
Filed: 5/19/2025ACC: 0000950170-25-074463
Officer· Chief Operating Officer
Since Dec 2023
-100K
Net shares
Net seller
$1.00M
Total acquired
1
Open market trades
0B · 1S
3
Total transactions
100K acquired · 200K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+100K
Price / share
$10.00
Trade value
$1M
% of position
227.3%
5/15/2025
44K→144K
Ordinary Shares
Direct
Shares
−100K
Price / share
—
Trade value
—
% of position
69.4%
5/15/2025
144K→44K
Total
Net shares
+0.00
Net value
$1M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 5/15/2025 | M · Option Exercise | +100K | $10.00 | $1M | 227.3% | 44K | 144K |
| Ordinary Shares Direct | 5/15/2025 | S · Sale | −100K | — | — | 69.4% | 144K | 44K |
| Total | +0.00 | $1M | ||||||
Derivative Transactions1
Option (right to buy)
Direct
Converts to
Ordinary Shares
100K shares
Shares
−100K
Strike price
10
Held after
450.93K
Exercisable
—
5/15/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option (right to buy) Direct | Ordinary Shares100K shares | 5/15/2025 | M · Option Exercise | −100K | 10 | — | 450.93K |